Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Chemoradiation With Capecitabine Plus Temozolomide in Patients With Locally Advanced Resectable Rectal Cancer: Phase I Study

NCT01781403 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01781403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Chemoradiation With Capecitabine Plus Temozolomide in Patients With Locally Advanced Resectable Rectal Cancer: Phase I Study
Lead sponsor
Asan Medical Center
Phase
Phase 1
Overall status
Completed
Start date
May 10, 2013
Completion date
May 4, 2016
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer